Inhibins and activins: Clinical advances in reproductive medicine

Clinical Endocrinology

Volumn 58, Issue 2, 2003, Pages 115-127

  Tong, Stephen ^a   Wallace, Euan M ^a   Burgert, Henry G ^b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; FOLLITROPIN; INHIBIN; INHIBIN A; TRANSFORMING GROWTH FACTOR BETA;

CELL VIABILITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FERTILIZATION IN VITRO; GRANULOSA CELL TUMOR; HORMONE ACTION; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MEASUREMENT; MENOPAUSE; MENSTRUAL CYCLE; NONHUMAN; OVARY CANCER; OVARY FUNCTION; PREGNANCY TEST; PRIORITY JOURNAL; PURIFICATION; REVIEW; SENSITIVITY AND SPECIFICITY; STRUCTURE ANALYSIS; TESTIS FUNCTION;

ACTIVINS; ANIMALS; BIOLOGICAL MARKERS; FEMALE; FETUS; FOLLICLE STIMULATING HORMONE; FOLLICULAR FLUID; HUMANS; INHIBINS; MALE; MENSTRUAL CYCLE; OVARIAN NEOPLASMS; OVARY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; REPRODUCTION; TESTIS;

EID: 0037322595     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01686.x     Document Type: Review

References (180)

1. Abe, Y., Hasegawa, Y., Miyamoto, K., Yamaguchi, M., Andoh, A., Ibuki, Y. & Igarashi, M. (1990) High concentrations of plasma immunoreactive inhibin during normal pregnancy in women. Journal of Clinical Endocrinology and Metabolism, 71, 133-137.
2. Aitken, D.A., Wallace, E.M., Crossley, J.A., Swanston, I.A., Vanpareren, Y., Vanmaarle, M., Groome, N.P., Macri, J.N. & Connor, J.M. (1996) Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. New England Journal of Medicine, 334, 1231-1236.
3. Ala-Fossi, S.L., Maenpaa, J., Blauer, M., Tuohimaa, P. & Punnonen, R. (2000) Inhibin A, B and pro-alpha C in serum and peritoneal fluid in postmenopausal patients with ovarian minors. European Journal of Endocrinology, 142, 334-339.
4. Anawalt, B.D., Bebb, R.A., Matsumoto, A.M., Groome, N.P., Illingworth, P.J., McNeilly, A.S. & Bremner, W.J. (1996) Serum inhibin B levels reflect sertoli cell function in normal men and men with testicular dysfunction. Journal of Clinical Endocrinology and Metabolism, 81, 3341-3345.
5. Andersson, A.M., Muller, J. & Skakkebaek, N.E. (1998) Different roles of prepubertal and postpubertal germ cells and sertoli cells in the regulation of serum inhibin B levels. Journal of Clinical Endocrinology and Metabolism, 83, 4451-4458.
6. Anderson, R.A., Wallace, E.M., Groome, N.P, Bellis, A.J. & Wu, F.C.W. (1997) Physiological relationships between inhibin B, follicle stimulating hormone secretion and sperrnatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone. Human Reproduction, 12, 746-751.
7. Anderson, R.A., Groome, N.P. & Baird, D.T. (1998a) Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clinical Endocrinology, 48, 577-584.
8. Anderson, R.A., Irvine, D.S., Balfour, C., Groome, N.P. & Riley, S.C. (1998b) Inhibin B in seminal plasma-testicular origin and relationship to spermatogenesis. Human Reproduction, 13, 920-926.
9. Aquilina, J., Barnett, A., Thompson, O. & Harrington, K. (1999) Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. American Journal of Obstetrics and Gynecology, 181, 131-136.
10. Attisano, L. & Wrana, J.L. (2002) Signal transduction by the TGF-beta superfamily. Science, 296, 1646-1647.
11. Badonnel, Y., Barbe, F., Legagneur, H., Poncelet, E. & Schweitzer, M. (1994) Inhibin as a marker for hydatidiform mole - a comparative study with the determinations of intact human chorionic gonadotrophin and its flee beta-subtmit. Clinical Endocrinology, 41, 155-162.
12. Ballesca, J.L., Balasch, J., Calafell, J.M., Alvarez, R., Fabregues, F., de Osaba, M.J., Ascaso, C. & Vanrell, J.A. (2000) Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoosperrnia. Human Reproduction, 15, 1734-1738.
13. Bergh, A. & Cajander, S. (1990) Immunohistochemical localization of inhibin-alpha in the testes of normal men and in men with testicular disorders. International Journal of Andrology, 13, 463-469.
14. Bhasin, S., De Kretser, D. & Drew, C.R. (1996) Measurement of circulating inhibin levels - revisiting the inhibin hypothesis. Journal of Clinical Endocrinology and Metabolism, 81, 1318-1320.
15. Bobrow, C.S., Holmes, R.P., Muttukrishna, S., Mohan, A., Groome, N., Murphy, D.J. & Soothill, P.W. (2002) Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and small-for-gestational-age fetuses classified by umbilical artery Doppler ultrasound. American Journal of Obstetrics and Gynecology, 186, 283-287.
16. Boggess, J.F., Soules, M.R., Goff, B.A., Greer, B.E., Cain, J.M. & Tamimi, H.K. (1997) Serum inhibin and disease status in women with ovarian granulosa cell rumors. Gynecologic Oncology, 64, 64-69.
17. Bohring, C. & Krause, W. (1999) Serum levels of inhibin B in men with different causes of spermatogenic failure. Andrologia, 31, 137-141.
18. Breit, S., Ashman, K., Wilting, J., Rossler, J., Hatzi, E., Fotsis, T. & Schweigerer, L. (2000) The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Research, 60, 4596-4601.
19. Buckler, H.M., Healy, D.L. & Burger, H.G. (1989) Purified FSH stimulates production of inhibin by the human ovary. Journal of Endocrinology, 122, 279-285.
20. Burger, H.G. (1993) Clinical review - clinical utility of inhibin measurements. Journal of Clinical Endocrinology and Metabolism, 76, 1391-1396.
21. Burger, H.G., Yamada, Y., Bangah, M.L., McCloud, P.I. & Warne, G.L. (1991) Serum gonadotropin, sex steroid, and immunoreactive inhibin levels in the first two years of life. Journal of Clinical Endocrinology and Metabolism, 72, 682-686.
22. Burger, H.G., Dudley, E.C., Hopper, J.L., Shelley, J.M., Green, A., Smith, A., Dennerstein, L. & Morse, C. (1995) The endocrinology of the menopausal transition - a cross-sectional study of a population-based sample. Journal of Clinical Endocrinology and Metabolism, 80, 3537-3545.
23. Burger, H.G., Robertson, D.M., Cahir, N., Mamers, P., Healy, D.L., Jobling, T. & Groome, N. (1996) Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Clinical Endocrinology, 44, 413-418.
24. Burger, H.G., Groome, N.P. & Robertson, D.M. (1998a) Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism, 83, 4167-4169.
25. Burger, H.G., Cahir, N., Robertson, D.M., Groome, N.P., Dudley, E., Green, A. & Dennerstein, L. (1998b) Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clinical Endocrinology, 48, 809-813.
26. Burger, H.G., Dudley, E.C., Hopper, J.L., Groome, N., Guthrie, J.R., Green, A. & Dennerstein, L. (1999) Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. Journal of Clinical Endocrinology and Metabolism, 84, 4025-4030.
27. Burger, H.G., Mamers, P. & Groome, N. (2000) Inhibins A and B are regulated differentially in the early post-parmm period. Clinical Endocrinology, 53, 149-153.
28. Burger, H.G., Fuller, P.J., Chu, S., Mamers, P., Drummond, A., Susil, B., Neva, P. & Robertson, D.M. (2001) The inhibins and ovarian cancer. Molecular and Celludar Endocrinology, 180, 145-148.
29. Byrd, W., Bennett, M.J., Carr, B.R., Dong, Y., Wians, F. & Rainey, W. (1998) Regulation of biologically active dimeric inhibin A and B from infancy to adulthood in the male. Journal of Clinical Endocrinology and Metabolism, 83, 2849-2854.
30. Casper, F.W., Seufert, R.J., Schaffrath, M. & Pollow, K. (2001) Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment. Fertility and Sterility, 75, 32-37.
31. Chong, H., Pangas, S.A., Bernard, D.J., Wang, E., Gitch, J., Chen, W., Draper, L.B., Cox, E.T. & Woodruff, T.K. (2000) Structure and expression of a membrane component of the inhibin receptor system. Endocrinology, 141, 2600-2607.
32. Coleman, M.A.G., France, J.T., Schellenberg, J.C., Anamev, V., Townend, K., Keelan, J.A., Groome, N.P. & McCowan, L.M.E. (2000) Corticotropin-releasing hormone, corticotropin-releasing hormone-binding protein, and activin A in maternal serum: Prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor. American Journal of Obstetrics and Gynecology, 183, 643-648.
33. Cuckle, H.S., Holding, S. & Jones, R. (1994) Maternal serum inhibin levels in second-trimester Down's Syndrome pregnancies. Prenatal Diagnosis, 14(5), 387-390.
34. Cuckle, H.S., Holding, S., Jones, R., Wallace, E.M. & Groome, N.P. (1995) Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies. Prenatal Diagnosis, 15, 385-386.
35. Cuckle, H.S., Holding, S., Jones, R., Groome, N.P. & Wallace, E.M. (1996) Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. Prenatal Diagnosis, 16, 1095-1100.
36. Cuckle, H., Sehmi, I. & Jones, R. (1998) Maternal serum inhibin A can predict pre-eclampsia. British Journal of Obstetrics and Gynaecology, 105, 1101-1103.
37. Cuevas, P., Ying, S.Y., Ling, N., Ueno, N., Esch, F., Guillemin, R., Healy, D. & S. (1987) Immunohistochemical detection of inhibin in the gonad. Biochemical and Biophysical Research Communications, 142, 23-30.
38. D'Antona, D., Mamers, P., Lowe, P.J.M., Balazs, N., Groome, N.P. & Wallace, E.M. (1998a) Evaluation of serum inhibin A as a surveillance marker after conservative management of tubal pregnancy. Human Reproduction, 13, 2305-2307.
39. D'Antona, D., Wallace, E.M., Shearing, C., Ashby, J.P. & Groome, N.P. (1998b) Inhibin A and pro-alpha C inhibin in Down's syndrome and normal pregnancies. Prenatal Diagnosis, 18, 1122-1126.
40. D'Antona, D., Reis, F.M., Benedetto, C., Evans, L.W., Groome, N.P., de Kretser, D.M., Wallace, E.M. & Petraglia, F. (2000) Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. Journal of Endocrinology, 165, 157-162.
41. Danforth, D.R., Arbogast, L.K., Mroueh, J., Kim, M.H., Kennard, E.A., Seifer, D.B. & Friedman, C.I. (1998) Dimeric inhibin - a direct marker of ovarian aging. Fertility and Sterility, 70, 119-123.
42. De Jong, F.H. & Sharpe, R.M. (1976) Evidence for inhibin-like activity in bovine follicular fluid. Nature, 263, 71-72.
43. De Kretser, D.M., McLachlan, R.I., Robertson, D.M. & Burger, H.G. (1989) Serum inhibin levels in normal men and men with testicular disorders. Journal of Endocrinology, 120, 517-523.
44. Derynck, T., Zhang, Y. & Feng, X.-H. (1998) Smads: transcriptional activators of TGF-β responses. Cell, 95, 737-740.
45. Draper, L.B., Chong, H., Wang, E. & Woodruff, T.K. (1997) The uterine myometrium is a target for increased levels of activin A during pregnancy. Endocrinology, 138, 3042-3046.
46. Dumesic, D.A., Damario, M.A., Session, D.R., Famuyide, A., Lesnick, T.G., Thornhill, A.R. & McNeilly, A.S. (2001) Ovarian morphology and serum hormone markers as predictors of ovarian sfollicle recruitment by gonadotrophins for in vitro fetilisation. Journal of Clinical Endocrinology and Metabolism, 86, 2538-2543.
47. Dzik, A., Lambert-Messerlian, G., Izzo, V.M., Soares, J.B., Pinotti, J.A. & Seifer, D.B. (2000) Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertility and Sterility, 74, 1114-1117.
48. Eldar-Geva, T., Robertson, D.M., Cahir, N., Groome, N., Gabbe, M.P., Maclachlan, V. & Healy, D.L. (2000) Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. Journal of Clinical Endocrinology and Metabolism, 85, 607-613.
49. Farrell, T., Chien, P.F.W. & Gordon, A. (1999) Intrapartum umbilical artery Doppler velocimetry as a predictor of adverse perinatal outcome: a systematic review. British Journal of Obstetrics and Gynaecology, 106, 783-792.
50. Findlay, J. (1986) The nature of inhibin and its use in the regulation of fertility and diagnosis of infertility. Fertility and Sterility, 46, 770-783.
51. Flemming, P., Grothe, W., Maschek, H., Petry, K.U., Wellmann, A. & Georgii, A. (1996) The site of inhibin production in ovarian neoplasms. Histopathology, 29, 465-468.
52. Florio, P., Benedetto, C., Luisi, S., Santuz, M., Di Carlo, C., Marozio, L., Genazzani, A.R. & Petraglia, F. (1999) Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery. British Journal of Obstetrics and Gynaecology, 106, 1061-1065.
53. Fowler, P.A., Evans, L.W., Groome, N.P., Templeton, A. & Knight, P.G. (1998) A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alpha C and follistatin during pregnancy. Human Reproduction, 13, 3530-3536.
54. Franchimont, P., Millet, D., Vendrrely, E., Letawe, J., Legros, J.J. & Netter, A. (1972) Relationship between spermatogenesis and serum gonadotrophin levels in azoospermia and oligospermia. Journal of Clinical Endocrinology and Metabolism, 34, 1003-1008.
55. Gebhart, J.B., Roche, P.C., Keeney, G.L., Lesnick, T.G. & Podratz, K.C. (2000) Assessment of inhibin and p53 in granulosa cell tumors of the ovary. Gynecologic Oncology, 77, 232-236.
56. Gilcrease, M.Z., Delgado, R. & Albores-Saavedra, J. (1998) Testicular sertoli cell manor with a heterologous sarcomatous component: immunohistochemical assessment of Sertoli cell differentiation. Archives of Pathology and Laboratory Medicine, 122, 907-911.
57. Groome, N.P., Illingworth, P.J., Obrien, M., Cooke, I., Ganesan, T.S., Baird, D.T. & McNeilly, A.S. (1994) Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clinical Endocrinology, 40, 717-723.
58. Groome, N.P., Illingworth, P.J., Obrien, M., Pai, R., Rodger, F.E., Mather, J.P. & McNeilly, A.S. (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism, 81, 1401-1405.
59. Gurusinghe, C.J., Healy, D.L., Jobling, T., Mamers, P. & Burger, H.G. (1995) Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecologic Oncology, 57, 27-32.
60. Hall, J.E., Welt, C.K. & Cramer, D.W. (1999) Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Human Reproduction, 14, 409-415.
61. Healy, D.L., McLachlan, I., Robertson, D.M., Okamato, S., Burger, H.G. & de Kretser, D.M. (1988) Human chorionic gonadotrophin and inhibin as placental hormones. Journal of Reproduction and Fertility Supplement, 36, 99-107.
62. Healy, D.L., Burger, H.G., Mamers, P., Jobling, T., Bangah, M., Quinn, M., Grant, P., Day, A.J., Rome, R. & Campbell, J.J. (1993) Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. New England Journal of Medicine, 329, 1539-1542.
63. Heldin, C.H., Miyazono, K. & Ten Dijke, P. (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465-471.
64. Henley, J.D., Young, R.H. & Ulbright, T.M. (2002) Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma. American Journal of Surgical Pathology, 26, 541-550.
65. Illingworth, P.J., Groome, N.P., Byrd, W., Rainey, W.E., McNeilly, A.S., Mather, J.P. & Bremner, W.J. (1996a) Inhibin-B - a likely candidate for the physiologically important form of inhibin in men. Journal of Clinical Endocrinology and Metabolism, 81, 1321-1325.
66. Illingworth, P.J., Groome, N.P., Duncan, W.C., Grant, V., Tovanabutra, S., Baird, D.T. & McNeilly, A.S. (1996b) Measurement of circulating inhibin forms during the establishment of pregnancy. Journal of Clinical Endocrinology and Metabolism, 81, 1471-1475.
67. Ishida, H., Tashiro, H., Watanahe, M., Fujii, N., Yoshida, H., Imamura, K., Minowada, S., Shinohara, M., Fukutani, K. & Aso, Y. (1990) Measurement of inhibin concentrations in men: study of changes after castration and comparison with androgen levels in testicular tissue, spermatic venous blood, and peripheral venous blood. Journal of Clinical Endocrinology and Metabolism, 70, 1019-1022.
68. Jacobs, I. (1994) Genetic, biochemical, and multimodal approaches to screening for ovarian cancer. Gynecologic Oncology, 55, S22-S27.
69. Jacobs, I. & Bast, R.C. Jr (1989) The CA 125 tumour-associated antigen: a review of the literature. Human Reproduction, 4, 1-12.
70. Jaffe, R.B., Spencer, S.J. & Rabinovici, J. (1993) Activins and inhibins: gonadal peptides during prenatal development and adult life. Annuals of the New York Academy of Sciences, 687, 1-9.
71. Jenkin, G., Ward, J., Hooper, S.B., O'Connor, A.E., de Kretser, D.M. & Wallace, E.M. (2001a) Feto-placental hypoxemia regulates the release of fetal activin A and prostaglandin E-2. Endocrinology, 142, 963-966.
72. Jenkin, G., Ward, J., Loose, J., Schneider-Kolsky, M., Young, R., Canny, B., O'Connor, A., de Kretser, D. & Wallace, E.M. (2001b) Physiological and regulatory roles of activin A in late pregnancy. Molecular and Cellular Endocrinology, 180, 131-138.
73. Jensen, T.K., Andersson, A.M., Hjollund, N.H.I., Scheike, T., Kolstad, H., Giwercman, A., Henriksen, T.B., Ernst, E., Bonde, J.P., Olsen, J., McNeilly, A., Groome, N.P. & Skakkebaek, N.E. (1997) Inhibin B as a serum marker of spermatogenesis - correlation to differences in sperm concentration and follicle-stimulating hormone levels - a study of 349 Danish men. Journal of Clinical Endocrinology and Metabolism, 82, 4059-4063.
74. Jobling, T., Mamers, P., Healy, D.L., Maclachlan, V., Burger, H.G., Quinn, M., Rome, R. & Day, A.J. (1994) A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecologic Oncology, 55, 285-289.
75. Kauppila, A., Bangah, M., Burger, H.G. & Martikainen, H. (1992) GnRH agonist analogue therapy in advanced/recurrent granulosa cell tumors: Further evidence of a role of inhibin in monitoring response to treatment. Gynaecologic Endocrinology, 6, 271-274.
76. Keelan, J.A., Marvin, K.W., Sato, T.A., McCowan, L.M.E., Coleman, M., Evans, L.W., Groome, N.P. & Mitchell, M.D. (1999) Concentrations of activin A, inhibin A and follistatin in human amnion, choriodecidual and placental tissues at term and preterm. Journal of Endocrinology, 163, 99-106.
77. Keogh, E.J., Lee, V., Rennie, G.C., Burger, H.G., Hudson, B. & de Kretser, D.M. (1976) Selective suppresion of FSH by testicular extracts. Endocrinology, 98, 997-1004.
78. Kinniburgh, D. & Anderson, R.A. (2001) Differential patterns of inhibin secretion in response to gonadotrophin stimulation in normal men. International Journal of Andrology, 24, 95-101.
79. Klein, N.A., Illingworth, P.J., Groome, N.P., McNeilly, A.S., Battaglia, D.E. & Soules, M.R. (1996) Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women - a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. Journal of Clinical Endocrinology and Metabolism, 81, 2742-2745.
80. Kozian, D.H., Ziche, M. & Augustin, H.G. (1997) The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Laboratory Investigation, 76, 267-276.
81. Kubini, K., Zachmann, M., Albers, N., Hiort, O., Bettendorf, M., Wolfle, J., Bidlingmaier, F. & Klingmuller, D. (2000) Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. Journal of Clinical Endocrinology and Metabolism, 85, 134-138.
82. Laivuori, H., Kaaja, R., Turpeinen, U., Stenman, U.H. & Ylikorkala, O. (1999) Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity. British Journal of Obstetrics and Gynaecology, 106, 1298-1303.
83. Lambert-Messerlian, G.M. (2000) Is inhibin a serum marker for ovarian cancer? European Journal of Endocrinology, 142, 331-333.
84. Lambert-Messerlian, G.M., Steinhoff, M., Zheng, W., Canick, J.A., Gajewski, W.H., Seifer, D.B. & Schneyer, A.L. (1997) Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Gynecologic Oncology, 65, 512-516.
85. Lambert-Messerlian, G.M., Luisi, S., Florio, P., Mazza, V., Canick, J.A. & Petraglia, F. (1998) Second trimester levels of maternal serum total activin A and placental inhibin/activin alpha and beta-A subunit messenger ribonucleic acids in Down's syndrome pregnancy. European Journal of Endocrinology, 138, 425-429.
86. Lappohn, R.E., Burger, H.G., Bouma, J., Bangah, M., Krans, M. & De Bruijn, H.W.A. (1989) Inhibin as a marker for granulosa-cell tumors. New England Journal of Medicine, 321, 790-793.
87. Le Gac, F. & de Kretser, D.M. (1982) Inhibin production by Sertoli cell cultures. Molecular and Cellular Endocrinology, 28, 487-498.
88. Lee, MM., Donahoe, P.K., Silverman, B.L., Hasegawa, T., Hasegawa, Y., Gustafson, M.L., Chang, Y.C. & MacLaughlin, D.T. (1997) Measurements of serum mullerian inhibiting substance in the evaluation of children with nonpalpable gonads. New England Journal of Medicine, 336, 1480-1486.
89. Lewis, K.A., Gray, PC., Blount, A.L., MacConell, L.A., Wiater, E., Bilezikjian, L.M. & Vale, W. (2000) Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature, 404, 411-414.
90. Ling, N., Ying, S.-Y., Ueno, N., Esch, F., Denoroy, L. & Guillemin, R. (1985) Isolation and partial characterisation of a Mr 32 000 protein with inhibin activity from porcine follicular fluid. Proceedings of the National Academy of Sciences of the USA, 82, 7217-7221.
91. Lockwood, G.M., Muttukrishna, S., Groome, N.P., Knight, P.G. & Ledger, W.L. (I996) Circulating inhibins and activin a during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clinical Endocrinology, 45, 741-748.
92. Lockwood, G.M., Ledger, W.L., Barlow, D.H., Groome, N.P. & Muttukrishna, S. (1997) Measurement of inhibin and activin in early human pregnancy - demonstration of fetoplacental origin and role in prediction of early-pregnancy outcome. Biology of Reproduction, 57, 1490-1494.
93. Main, K.M., Schmidt, I.M. & Skakkebaek, N.E. (2000) A possible role for reproductive hormones in newborn boys: progressive hypogonadism without the postnatal testosterone peak. Journal of Clinical Endocrinology and Metabolism, 85, 4905-4907.
94. Majdic, G., McNeilly, A.S., Sharpe, R.M., Evans, L.R., Groome, N.P. & Saunders, P.T.K. (1997) Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and neonate and during postnatal development in the rat. Endocrinology, 138, 2136-2147.
95. Manuelpillai, U., Schneider-Kolsky, M., Dole, A. & Wallace, E.M. (2001) Activin A and activin receptors in gestational tissue from preeclamptic pregnancies. Journal of Endocrinology, 171, 57-64.
96. Manuelpillai, U., Schneider-Kolsky, M., Thirunavukarasu, P., Dole, A., Waldron, K. & Wallace, E.M. (2002) Effect of hypoxia on placental activin A, inhibin A and follistatin synthesis. Placenta, in press.
97. Mathews, L.S. (1994) Activin receptors and cellular signaling by the receptor serine kinase family. Endocrine Reviews, 15, 310-235.
98. McCarthy, S.A. & Bicknell, R. (1993) Inhibition of vascular endothelial growth by activin-A. Journal of Biological Chemistry, 268, 23066-23071.
99. McCluggage, W.G. & Maxwell, P. (1999) Adenocarcinomas of various sites may exhibit immunoreactivity with anti-inhibin antibodies. Histopathology, 35, 216-220.
100. McCullagh, D.R. (1932) Dual endocrine role of the testis. Science, 76, 19-20.
101. McGuire, V., Jesser, C.A. & Whittemore, A.S. (2002) Survival among U.S. women with invasive epithelial ovarian cancer. Gynaecologic Oncology, 84, 399-403.
102. McLachlan, R.I., Robertson, D.M., Healy, D.L., de Kretser, D.M. & Burger, H.G. (1986a) Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF: a new index of follicular function? Lancet, 1, 1233-1234.
103. McLachlan, R.I., Robertson, D.M., Burger, H.G. & de Kretser, D.M. (1986b) The radioimmunoassay of bovine and human follicular fluid and serum inhibin. Molecular and Cellular Endocrinology, 46, 175-185.
104. McLachlan, R.I., Healy, D.L., Lutjen, P.J., Findlay, J.K., De Kretser, M. & Burger, H.G. (1987a) The maternal ovary is not the source of circulating inhibin levels during human pregnancy. Clinical Endocrinology, 27, 663-668.
105. McLachlan, R.I., Robertson, D.M., Healy, D.L., Burger, H.G. & de Kretser, D.M. (1987b) Circulating immunoreactive inhibin levels during the normal human menstrual cycle. Journal of Clinical Endocrinology and Metabolism, 65, 954-961.
106. Meachem, S.J., Nieschlag, E. & Simoni, M. (2001) Inhibin B in male reproduction: pathophysiology and clinical relevance. European Journal of Endocrinology, 145, 561-571.
107. Menon, U., Riley, S.C., Thomas, J., Bose, C., Dawnay, A., Evans, L.W., Groome, N.P. & Jacobs, I.J. (2000) Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma. British Journal of Obstetrics and Gynaecology, 107, 1069-1074.
108. Mohan, A., Asselin, J., Sargent, I.L., Groome, N.P. & Muttukrishna, S. (2001) Effect of cytokines and growth factors on the secretion of inhibin A, activin A and follistatin by term placental villous trophoblasts in culture. European Journal of Endocrinology, 145, 505-511.
109. Muttukrishna, S., Fowler, P.A., George, L., Groome, N.P. & Knight, P.G. (1996) Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. Journal of Clinical Endocrinology and Metabolism, 81, 3328-3334.
110. Muttukrishna, S., Child, T.J., Groome, N.P. & Ledger, W.L. (1997a) Source of circulating levels of inhibin A, pro alpha c-containing inhibins and activin A in early pregnancy. Human Reproduction, 12, 1089-1093.
111. Muttukrishna, S., Knight, P.G., Groome, N.P., Redman, C.W. & Ledger, W.L. (1997b) Activin A and mhibin A as possible endocrine markers for pre-eclampsia. Lancet, 349, 1285-1288.
112. Muttukrishna, S., North, R.A., Morris, J., Schellenberg, J.C., Taylor, R.S., Asselin, J., Ledger, W., Groome, N. & Redman, C.W.G. (2000) Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Human Reproduction, 15, 1640-1645.
113. Noble, P.L., Wallace, E.M., Snijders, R.J., Groome, N.P. & Nicolaides, K.H. (1997) Maternal serum inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10-14 weeks of gestation. British Journal of Obstetrics and Gynaecology, 104, 367-371.
114. Pearlstone, A.C., Fournet, N., Gambone, J.C., Pang, S.C. & Buyalos, R.P. (1992) Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age. Fertility and Sterility, 58, 674-679.
115. Pelkey, T.J., Frierson, H.F. Jr, Mills, S.E. & Stoler, M.H. (1998) The diagnostic utility of inhibin staining in ovarian neoplasms. International Journal of Gynecological Pathology, 17, 97-105.
116. Perheentupa, A., Critchley, H.O.D., Illingworth, P.J. & McNeilly, A.S. (2000) Enhanced sensitivity to steroid-negative feedback during breast-feeding: low-dose estradiol (transdermal estradiol supplementation) suppresses gonadotrophins and ovarian activity assessed by inhibin B. Journal of Clinical Endocrinology and Metabolism, 85, 4280-4286.
117. Petraglia, F., Calza, L., Garuti, G.C., Abrate, M., Giardino, L., Genazzani, A.R., Vale, W. & Meunier, H. (1990) Presence and synthesis of inhibin subunits in human decidua. Journal of Clinical Endocrinology and Metabolism, 71, 487-492.
118. Petraglia, F., Anceschi, M.M., Calza, L., Garuti, G.C., Fusaro, P., Giardino, L., Genazzani, A.R. & Vale, W. (1993) Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. Journal of Clinical Endocrinology and Metabolism, 77, 542-548.
119. Petraglia, F., Gallinelli, A., Devita, D., Lewis, K., Mathews, L. & Vale, W. (1994) Activin at parturition - changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes. Obstetrics and Gynecology, 84, 278-282.
120. Petraglia, F., Aguzzoli, L., Gallinelli, A., Florio, P., Zonca, M., Benedetto, C. & Woodruff, K. (1995) Hypertension in pregnancy - changes in activin A maternal serum concentration. Placenta, 16, 447-454.
121. Petraglia, F., Diblasio, A.M., Florio, P., Gallo, R., Genazzani, A.R., Woodruff, T.K. & Vale, W. (1997) High levels of fetal membrane activin beta-A and activin receptor IIb mRNAs and augmented concentration of arnniotic fluid activin A in women in term or preterm labor. Journal of Endocrinology, 154, 95-101.
122. Petraglia, F., Luisi, S., Pautier, P., Sabourin, J.C., Rey, R., Lhomme, C. & Bidart, J.M. (1998) Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. Journal of Clinical Endocrinology and Metabolism, 83, 1029-1032.
123. Phipps, M.G., Hogan, J.W., Peipert, J.F., Lambert-Messerlian, G.M., Canick, J.A. & Seller, D.B. (2000) Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies. Obstetrics and Gynecology, 95, 227-231.
124. Pierik, F.H., Vreeburg, J.T.M., Stijnen, T., Dejong, F.H. & Weber, R.F.A. (1998) Serum inhibin B as a marker of spermatogenesis. Journal of Clinical Endocrinology and Metabolism, 83, 3110-3114.
125. Qu, J.P., Vankreiken, L., Brulet, C. & Thomas, K. (1991) Circulating bioactive inhibin levels during human pregnancy. Journal of Clinical Endocrinology and Metabolism, 72, 862-866.
126. Raivio, T., Toppari, J., Perheentupa, A., McNeilly, A.S. & Dunkel, L. (1997) Treatment of prepubertal gonadotrophin-deficient boys with recombinant human follicle-stimulating hormone. Lancet, 350, 263-264.
127. Ramaswamy, S., Marshall, G.R., McNeilly, A.S. & Plant, T.M. (1999) Evidence that in a physiological setting sertoli cell number is the major determinant of circulating concentrations of inhibin B in the adult male rhesus monkey (Macaca mulatta). Journal of Andrology, 20, 430-434.
128. Reddi, K., Wickings, E.J., McNeilly, A.S., Baird, D.T. & Hillier, S.G. (1990) Circulating bioactive follicle stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle. Clinical Endocrinology, 33, 547-557.
129. Reyes, F.I., Boroditsky, R.S., Winter, J.S. & Faiman, C. (1974) Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations. Journal of Clinical Endocrinology and Metabolism, 38, 612-617.
130. Richardson, S.J., Senikas, V. & Nelson, J.F. (1987) Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. Journal of Clinical Endocrinology and Metabolism, 65, 1231-1237.
131. Risbridger, G.P. & Cancilla, B. (2000) Role of activins in the male reproductive tract. Reviews of Reproduction, 5, 99-104.
132. Risbridger, G.P., Clements, J., Robertson, D.M., Drummond, A.E., Muir, J., Burger, H.G. & de Kretser, D.M. (1989) Immuno- and bioactive inhibin and inhibin alpha-subunit expression in rat Leydig cell cultures. Molecular and Cellular Endocrinology, 66, 119-122.
133. Roberts, V.J. & Barth, S.L. (1994) Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology, 134, 914-923.
134. Roberts, J.M., Taylor, R.M., Musci, T.J., Rodgers, G.M., Hubel, C.A. & McLaughlin, M.K. (1989a) Pre-eclampsia: an endothelial cell disorder. American Journal of Obstetrics and Gynecology, 161, 1200-1204.
135. Roberts, V., Meunier, H., Sawchenko, P.E. & Vale, W. (1989b) Differential production and regulation of inhibin subunits in rat testicular cell types. Endocrinology, 125, 2350-2359.
136. Robertson, D., Burger, H.G., Sullivan, J., Cahir, N., Groome, N., Poncelet, E., Franchimont, P., Woodruff, T. & Mather, J.P. (1996) Biological and immunological characterization of inhibin forms in human plasma. Journal of Clinical Endocrinology and Metabolism, 81, 669-676.
137. Robertson, D., Cahir, N., Findlay, J.K., Burger, H.G. & Groome, N. (1997) The biological and immunological characterisation of inhibin A and B forms in human follicular fluid and plasma. Journal of Clinical Endocrinology and Metabolism, 82, 889-896.
138. Robertson, D.M., Foulds, L.M., Leversha, L., Morgan, F.J., Hearn, M.T., Burger, H.G., Wettenhall, R.E. & de Kretser, D.M. (1985) Isolation of inhibin from bovine follicular fluid. Biochemical and Biophysical Research Communications, 126, 220-226.
139. Robertson, D.M., Cahir, N., Burger, H.G., Mamers, P., McCloud, P.I., Pettersson, K. & McGuckin, M. (1999a) Combined inhibin and CA 125 assays in the detection of ovarian cancer. Clinical Chemistry, 45, 651-658.
140. Robertson, D.M., Cahir, P., Burger, H.G., Mamers, P. & Groome, N. (1999b) Inhibin forms in serum from postmenopausal women with ovarian cancers. Clinical Endocrinology, 50, 381-386.
141. Robertson, D.M., Stephenson, T., Pruysers, E., McCloud, P., Tsigos, A., Groome, N., Mamers, P. & Burger, H.G. (2002) Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer. Journal of Clinical Endocrinology and Metabolism, 87, 816-824.
142. Schneider-Kolsky, M., D'Antona, D., Evans, L.W., Taylor, N., O'Connor, A., Groome, N.P., de Kretser, D. & Wallace, E.M. (2000a) Maternal serum total activin A and follistatin in pregnancy and parturition. British Journal of Obstetrics and Gynaecology, 107, 995-1000.
143. Schneider-Kolsky, M., Jenkin, G., Groome, N. & Wallace, E. (2000b) Increased maternal serum activin A in association with intra-uterine fetal growth restriction. Presented at the 11th International Congress of Endocrinology, Sydney.
144. Schneider-Kolsky, M., Manuelpillai, U., Gargett, C. & Wallace, E.M. (2001) Activin betaA-subunit and activin receptors in human myometrium at term and during labour. British Journal of Obstetrics and Gynaecology, 108, 869-874.
145. Schneyer, A.L., Mason, A.J., Burton, L.E., Ziegner, J.R. & Crowley, W.F. Jr (1990) Immunoreactive inhibin alpha-subunit in human serum: implications for radioimmunoassay. Journal of Clinical Endocrinology and Metabolism, 70, 1208-1212.
146. Schubert, D., Kimura, H., LaCorbiere, J., Vaughan, J., Karr, D. & Fischer, W.H. (1990) Activin is a nerve cell survival molecule. Nature, 344, 868-870.
147. Scott, R.T., Toner, J.P., Muasher, S.J., Oehninger, S., Robinson, S. & Rosenwaks, Z. (1989) Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertility and Sterility, 51, 651-654.
148. Seifer, D.B., Gardiner, A.C., Lambert-Messerlian, G. & Schneyer, A.L. (1996a) Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. Journal of Clinical Endocrinology and Metabolism, 81, 736-739.
149. Seifer, D.B., Lambert-Messerlian, G.M., Canick, J.A., Frishman, G.N. & Schneyer, A.L. (1996b) Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies. Fertility and Sterility, 65, 667-669.
150. Seifer, D.B., Lambert-Messerlian, G., Hogan, J.W., Gardiner, A.C., Blazar, A.S. & Berk, C.A. (1997) Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertility and Sterility, 67, 110-114.
151. Setchell, B.P. & Jacks, F. (1974) Inhibin like activity in rete testis fluid. Endocrinology, 62, 675-676.
152. Silver, H.M., Lambert-Messerlian, G.M., Star, J.A., Hogan, J. & Canick, J.A. (1999) Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. American Journal of Obstetrics and Gynecology, 180, 1131-1137.
153. Spencer, K., Wood, P.J. & Anthony, F.W. (1993) Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's Syndrome. Annals of Clinical Biochemistry, 30(1), 219-220.
154. Spencer, K., Liao, A.W., Ong, C.Y.T., Geerts, L. & Nicolaides, K.H. (2001) Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester. Prenatal Diagnosis, 21, 441-444.
155. Tabei, T., Ochiai, K., Terashima, Y. & Takanashi, N. (1991) Serum levels of inhibin in maternal and umbilical blood during pregnancy. American Journal of Obstetrics and Gynecology, 164, 896-900.
156. Tena-Sempere, M., Kero, J., Rannikko, A., Yan, W. & Huhtaniemi, I. (1999) The pattern of inhibin/activin alpha- and beta (B)-subunit messenger ribonucleic acid expression in rat testis after selective Leydig cell destruction by ethylene dimethane sulfonate. Endocrinology, 140, 5761-5770.
157. Thirunavukarasu, P., Stephenson, T., Forray, J., Stanton, P.G., Groome, N.P., Wallace, E.M. & Robertson, D.M. (2001) Changes in molecular weight forms of inhibin A and Pro-C in maternal serum during human pregnancy. Journal of Clinical Endocrinology and Metabolism, 86, 5794-5804.
158. Thirunavukarasu, P.P., Lambert-Messerlian, G., Robertson, D.R., Dawson, G., Canick, J. & Wallace, E.M. (2002) Molecular weight forms of inhibin A, inhibin B and proC in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies. Prenatal Diagnosis, in press.
159. Tovanabutra, S., Illingworth, P.J., Ledger, W.L., Glasier, A.F. & Baird, D.T. (1993) The relationship between peripheral immunoreactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy. Clinical Endocrinology, 38, 101-107.
160. Treetampinich, C., O'Connor, A.E., MacLachlan, V., Groome, N.P. & de Kretser, D.M. (2000) Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome. Human Reproduction, 15, 2028-2032.
161. Tuuri, T., Eramaa, M., Hilden, K. & Ritvos, O. (1994) The tissue distribution of activin beta A- and beta B-subumt and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. Journal of Clinical Endocrinology and Metabolism, 78, 1521-1524.
162. Ulbright, T.M., Srigley, J.R., Reuter, V.E., Wojno, K., Roth, L.M. & Young, R.H. (2000) Sex cord-stromal tumors of the testis with entrapped germ cells: a lesion mimicking unclassified mixed germ cell sex cord-stromal rumors. American Journal of Surgical Pathology, 24, 535-542.
163. Vale, W., Rivier, J., Vaughan, J., McClintock, R., Corrigan, A., Woo, W., Karr, D. & Spiess, J. (1986) Purification and characterisation of an FSH releasing protein from porcine ovarian follicular fluid. Nature, 321, 776-779.
164. Van Lith, J.M., Pratt, J.J., Beekhuis, J.R. & Matingh, A. (1992) Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's Syndrome. Prenatal Diagnosis, 12(10), 441-444.
165. von Eckardstein, S., Simoni, M., Bergmann, M., Weinbauer, G.F., Gassner, P., Schepers, A.G. & Nieschlag, E. (1999) Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. Journal of Clinical Endocrinology and Metabolism, 84, 2496-2501.
166. Wallace, E. (1996) Inhibins: new tumour markers in gynaecology. Tumour Marker Update, 8, 105-110.
167. Wallace, E.M., Harkness, L.M., Burns, S. & Liston, W.A. (1994) Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome. Clinical Endocrinology, 41, 483-486.
168. Wallace, E.M., Grant, V.E., Swanston, I.A. & Groome, N.P. (1995) Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome. Prenatal Diagnosis, 15, 359-362.
169. Wallace, E.M., Swanston, I.A., McNeilly, A.S., Ashby, J.P., Blundell, G., Calder, A.A. & Groome, N.P. (1996) Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clinical Endocrinology, 44, 17-21.
170. Wallace, E.M., Groome, N.P., Riley, S.C., Parker, A.C. & Wu, F.C. (1997a) Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. Journal of Clinical Endocrinology and Metabolism, 82, 3111-3115.
171. Wallace, E.M., Riley, S.C., Crossley, J.A., Ritoe, S.C., Home, A., Shade, M., Ellis, P.M., Aitken, D.A. & Groome, N.P. (1997b) Dimeric inhibins in amniotic fluid, maternal and fetal serum in human pregnancy. Journal of Clinical Endocrinology and Metabolism, 82, 218-222.
172. Wang, E.Y., Woodruff, T.K., Moawad, A., for the NICHHD, M.F.M. & Units Network. (2002) Follistatin-free activin A is not associated with preterm birth. American Journal of Obstetrics and Gynecology, 186, 464-469.
173. Welt, C.K., McNicholl, D.J., Taylor, A.E. & Hall, J.E. (1999) Female reproductive aging is marked by decreased secretion of dimeric inhibin. Journal of Clinical Endocrinology and Metabolism, 84, 105-111.
174. Wenstrom, K.D., Owen, J., Chu, D.C. & Boots, L. (1997) Alphafetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down's syndrome. American Journal of Obstetrics and Gynecology, 177, 987-991.
175. Winter, J.S. (1982) Hypothalamic-pituitary function in the fetus and infant. Clinics in Endocrinology and Metabolism, 11, 41-55.
176. Wong, W.L.T., Garg, S.J., Woodruff, TIC, Bald, L., Fendly, B. & Lofgren, J.A. (1993) Monoclonal antibody based ELISAs for measurement of activins in biological fluids. Journal of Immunological Methods, 165, 1-10.
177. Wu, D.D., Lai, M., Hughes, P.E., Sirimanne, E., Gluckman, P.D. & Williams, C.E. (1999) Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Research, 835, 369-378.
178. Yohkaichiya, T., Fukaya, T., Hoshiai, H., Yajima, A. & de Kretser, D.M. (1989) Inhibin: a new circulating marker of hydatidiform mole? British Medical Journal, 298, 1684-1686.
179. Young, J., Couzinet, B., Chanson, P., Brailly, S., Loumaye, E. & Schaison, G. (2000) Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. Journal of Clinical Endocrinology and Metabolism, 85, 3239-3244.
180. Yu, J., Shao, L. & Lemas, V., YuA.L., Vaughan, J., Rivier, J. & Vale, W. (1987) Importance of FSH-releasing protein and inhibin in erythro-differentiation. Nature, 330, 765-767.